deflazacort has been researched along with eicosapentaenoic acid in 1 studies
| Studies (deflazacort) | Trials (deflazacort) | Recent Studies (post-2010) (deflazacort) | Studies (eicosapentaenoic acid) | Trials (eicosapentaenoic acid) | Recent Studies (post-2010) (eicosapentaenoic acid) |
|---|---|---|---|---|---|
| 452 | 99 | 115 | 7,171 | 1,304 | 3,623 |
| Protein | Taxonomy | deflazacort (IC50) | eicosapentaenoic acid (IC50) |
|---|---|---|---|
| Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | Homo sapiens (human) | 4 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 7.1 | |
| Oxoeicosanoid receptor 1 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apolinário, LM; Carvalho, SC; Marques, MJ; Matheus, SM; Santo Neto, H | 1 |
1 other study(ies) available for deflazacort and eicosapentaenoic acid
| Article | Year |
|---|---|
EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype.
Topics: Analysis of Variance; Animals; Antigens, Differentiation; Creatine Kinase; Disease Models, Animal; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Female; Interferon-gamma; Interleukin-10; Lectins, C-Type; Macrophages; Male; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscles; Muscular Dystrophy, Duchenne; Nitric Oxide Synthase Type II; Phenotype; Pregnenediones; Receptors, Cell Surface | 2013 |